More Data Back Common Drugs as Adjuncts for Cancer

(MedPage Today) -- Recurrence after surgery for colorectal cancer (CRC) declined by almost two-thirds in patients who received a short course of a COX2 inhibitor and a beta blocker, a small randomized trial showed.
Patients who received the drugs...